Lv1
10 积分 2024-04-17 加入
局限期小细胞肺癌预防性脑照射后脑转移相关危险因素分析
1小时前
待确认
[Consensus on immunotherapy for small cell lung cancer(2024 edition)]
8天前
已完结
非小细胞肺癌新辅助治疗疗效病理评估专家共识
2个月前
已完结
First-line camrelizumab plus pemetrexed and carboplatin for advanced non-squamous non-small-cell lung cancer with brain metastases (CAP-BRAIN): final results of a multicentre, open-label, single-arm, phase 2 trial in China
2个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
4个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
4个月前
已完结
皖公网安备34019202002308
